Pseudomonas Infections Global Clinical Trials Review, H1, 2018

Region:Global

Author(s):

Product Code:GDHC5047CTIDB

Download Sample Report download
Buy the Full ReportStarting from $2500
Published on

June 2018

Total pages

126

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2500

About the Report

About the Report

Pseudomonas Infections Global Clinical Trials Review, H1, 2018

 

Summary

 

GlobalData's clinical trial report, Pseudomonas Infections Global Clinical Trials Review, H1, 2018" provides an overview of Pseudomonas Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Pseudomonas Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

 

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Reasons to buy

 

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Products

Products

Pseudomonas Infections Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Pseudomonas Infections, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania


Companies

Gilead Sciences Inc

Novartis AG

Cystic Fibrosis Foundation

Insmed Inc

Polyphor AG

PARI Medical Holding GmbH

Humanigen Inc

F. Hoffmann-La Roche Ltd

Bayer AG

AmpliPhi Biosciences Corp

Table of Contents

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Pseudomonas Infections to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Pseudomonas Infections to Infectious Disease Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Pseudomonas Infections Therapeutics Clinical Trials 28

Prominent Drugs 29

Latest Clinical Trials News on Pseudomonas Infections 30

May 30, 2018: Geom Therapeutics To Present Data From Antibiotic Drug Development Programs At ASM Microbe 30

Apr 20, 2018: Basilea reports presentations of ceftobiprole data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 30

Clinical Trial Profile Snapshots 32

Appendix 124

Abbreviations 124

Definitions 124

Research Methodology 125

Secondary Research 125

About GlobalData 126

Contact Us 126

Source 126


List of Figure

List of Figures

Pseudomonas Infections Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Pseudomonas Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Pseudomonas Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Pseudomonas Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10

Pseudomonas Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11

Pseudomonas Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12

Pseudomonas Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13

Pseudomonas Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14

Proportion of Pseudomonas Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 15

Pseudomonas Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Pseudomonas Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Pseudomonas Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 18

Pseudomonas Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Pseudomonas Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20

Pseudomonas Infections Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21

Pseudomonas Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22

Pseudomonas Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23

Pseudomonas Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24

Pseudomonas Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25

Pseudomonas Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26

Pseudomonas Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27

Pseudomonas Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28

Pseudomonas Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

GlobalData Methodology 125


List of Table

List of Tables

Pseudomonas Infections Therapeutics, Global, Clinical Trials by Region, 2018* 7

Pseudomonas Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Pseudomonas Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Pseudomonas Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10

Pseudomonas Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11

Pseudomonas Infections Therapeutics Clinical Trials, North America, Top Countries, 2018* 12

Pseudomonas Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13

Pseudomonas Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14

Proportion of Pseudomonas Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 15

Pseudomonas Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Pseudomonas Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Pseudomonas Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 18

Pseudomonas Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Pseudomonas Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20

Pseudomonas Infections Therapeutics, Global, Clinical Trials by Phase, 2018* 21

Pseudomonas Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22

Pseudomonas Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23

Pseudomonas Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24

Pseudomonas Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25

Pseudomonas Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26

Pseudomonas Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27

Pseudomonas Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28

Pseudomonas Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022